Exome Sequencing Reveals Novel Variants in Genetic Skeletal Disorders: Insights From a Cohort in Southwest Iran
Clinical Genetics · 2026
DOI: 10.1111/cge.70070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2026. Verfasst von Rezvan Zabihi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran. Hauptthemen laut MEDLINE: Exome Sequencing, Receptor, Fibroblast Growth Factor, Type 3, Osteogenesis Imperfecta, Genetic Predisposition to Disease. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Genetic skeletal disorders (GSDs) comprise a diverse group of disorders that affect bone development and homeostasis. In some areas of Iran, GSD occurs more frequently than in other places for still unknown reasons. The aim of this study was to characterize the genetic landscape of GSDs in a cohort from southwestern Iran using Exome sequencing (ES), with a focus on identifying pathogenic and likely pathogenic variants. Osteogenesis Imperfecta (OI) was the most prevalent disorder, with an unexpectedly high frequency of autosomal recessive subtypes, likely due to a high consanguinity rate (61.3%) in the cohort. Achondroplasia (ACH) was the second most common disease and, comparable to another population, the NM_000142.5:c.1138G>A, p.(Gly380Arg), was the most common variant in FGFR3 . ES identified twenty novel and fifteen previously reported pathogenic variants in several genes associated with GSDs. We provide the first comprehensive ES‐based molecular diagnosis of GSDs in an Iranian population and uncover novel pathogenic variants that expand the known spectrum of variants. The results underscore the importance of genetic testing in the diagnosis of rare skeletal diseases and highlight the need for targeted genetic counseling in populations with high consanguinity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
- Narges Medical Genetics and Prenatal Diagnosis Laboratory, Ahvaz, Iran.
- Department of Dermatology, School of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Obstetrics and Gynecology, Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
ORCID-Profile: Rezvan Zabihi, Mohammad Hamid
Zitieren
APA
Zabihi, R., Zamani, M., Chamanrou, N., Zeighami, J., Seifi, T., Ashoori, S., Parvas, S., Yadegari, T., Mousavi, F., Khajevandian, E., Sarvari, M., Shojaei, K., Nourbakhsh, P., Keikhaei, B., Aminzadeh, M., Ahmadi, R., Anaei, M. M., Sedaghat, A., Saberi, A., …, & Galehdari, H. (2026). Exome Sequencing Reveals Novel Variants in Genetic Skeletal Disorders: Insights From a Cohort in Southwest Iran. Clinical Genetics. https://doi.org/10.1111/cge.70070
Vancouver
Zabihi R, Zamani M, Chamanrou N, Zeighami J, Seifi T, Ashoori S, et al. Exome Sequencing Reveals Novel Variants in Genetic Skeletal Disorders: Insights From a Cohort in Southwest Iran. Clinical Genetics. 2026. doi:10.1111/cge.70070
BibTeX
@article{Zabihi2026,
author = {Zabihi, Rezvan and Zamani, Mina and Chamanrou, Niloofar and Zeighami, Jawaher and Seifi, Tahere and Ashoori, Saeed and Parvas, Sahere and Yadegari, Tahere and Mousavi, Fateme and Khajevandian, Elham and Sarvari, Moslem and Shojaei, Kobra and Nourbakhsh, Pardis and Keikhaei, Bijan and Aminzadeh, Majid and Ahmadi, Raha and Anaei, Marzieh Mohammadi and Sedaghat, Alireza and Saberi, Alihossein and Hamid, Mohammad and Shariati, Golamreza and Galehdari, Hamid},
title = {Exome Sequencing Reveals Novel Variants in Genetic Skeletal Disorders: Insights From a Cohort in Southwest Iran},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70070}
}
EUVIMED